Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design.
about
Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten CarrierCAF01 potentiates immune responses and efficacy of an inactivated influenza vaccine in ferretsDifferential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutininActivation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.Live attenuated influenza virus vaccines by computer-aided rational design.PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity.Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope predictionAnalyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins.Characterization of full-length MHC class II sequences in Indonesian and Vietnamese cynomolgus macaquesImmunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoproteinThe utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infectionTrivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.Orchestration of CD4 T cell epitope preferences after multipeptide immunization.Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.Critical role of glycosylation in determining the length and structure of T cell epitopes.Cellular and molecular mechanisms of memory T-cell survival.T cell immunodominance is dictated by the positively selecting self-peptideEfficacy and safety of influenza vaccination in children with asthma.Computer-aided design of T-cell epitope-based vaccines: addressing population coverage.The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity.Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.A Possible Role for Idiotype/Anti-idiotype B-T Cell Interactions in Maintaining Immune Memory.Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.CD4(+) T-cell inhibitory ligands: a tool for characterizing dysfunctional CD4(+) T cells during chronic infection.Aryl hydrocarbon receptor signaling modulates antiviral immune responses: ligand metabolism rather than chemical source is the stronger predictor of outcome.
P2860
Q28542642-F757BDEE-4214-46A1-8932-8FBCE4C974B8Q28741710-D7920D82-7954-488A-8229-8F9C313A52DBQ30353821-339B78D6-92EF-4897-89D2-6DBFBBDB5234Q30361736-C0851180-7E96-43A2-90E2-F92B74D0A2CBQ30367140-0296ECC8-19A6-4E50-A57C-A91A3E0F198FQ30376369-865918DF-08A9-4995-94D8-EA0212C82159Q30390286-1C96F876-7E48-4E7D-B6CE-39B1DDD3CA36Q31111090-72D73051-0AF3-4C8B-AB10-FB707858F488Q33900413-E8900863-CEEF-4000-AA9D-C699FCA4E42CQ33905228-1A9AC19B-8D88-4E14-8167-0B7BAE741C97Q33912582-279F0069-B4C7-4CFD-B57C-379B7B2FFF73Q34261503-533481F8-A964-4547-A170-C496EB2CD4B9Q35903181-6233300C-2853-433D-BA7E-175AA8077E4FQ36950550-2CDD0C63-3F87-4749-AD93-28DC580BDDE2Q37092152-572D2A68-E3CC-4236-A4DC-73E60F3DAD3EQ37258244-186338F8-6CF1-45BA-AB4F-540B6D3CFB8AQ37384080-3B3309F9-0D50-4DB2-9CC3-0DE61188E191Q37403487-50CBD324-A422-4F4A-AE8E-335C53C5E474Q37453545-2E3C31DB-3ADC-4149-B12B-E8F986CA58BBQ38006995-1D59B6D3-51DE-43D9-8A6E-ABD213635B45Q38554524-F9C0625B-B602-4844-B2EA-C5E7E49B74C4Q39553544-6E91CB8D-E932-405B-9234-A96321A9C02DQ41910764-CD120AB9-8129-4516-9320-2B7C2012D5E5Q41973429-CB2F8E37-E5A1-4777-9F10-6B8D22C08C35Q42925957-893E9F61-2064-48F0-8B6A-40E0DEB89CB9Q46135981-A021BA96-4F69-4693-9412-C4FB009349CCQ47548120-C6328CE0-3EFB-4B7D-8F28-1497A77AAB20
P2860
Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunodominance in CD4 T-cell ...... virus and for vaccine design.
@en
type
label
Immunodominance in CD4 T-cell ...... virus and for vaccine design.
@en
prefLabel
Immunodominance in CD4 T-cell ...... virus and for vaccine design.
@en
P2093
P2860
P356
P1476
Immunodominance in CD4 T-cell ...... virus and for vaccine design.
@en
P2093
Andrea J Sant
Christopher A Lazarski
Francisco A Chaves
Frederick R Krafcik
Jason M Weaver
Katherine Richards
Paula Menges
P2860
P304
P356
10.1586/14760584.6.3.357
P577
2007-06-01T00:00:00Z